The overwhelming majority of Chinese COVID vaccines have been sold to middle-income countries with only about 2% going to low-income states, according to new research by the China Power Project at the Center for Strategic Studies (CSIS) in Washington, D.C.
Since 90+% of Chinese vaccine distributions around the world have been in the form of sales, most of the world’s poorest countries simply don’t have the resources to procure vaccines from China.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.